AKTS CIK: 2035832

Aktis Oncology, Inc.

  • United States
  • Technology
Metrics score locked — part of Premium
FY23
FY23
FY24
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY23:
−43.8
FY23:
−26.1
FY24:
−83.8
FY24:
17.2
FY25:
−64.1
Change from FY23 to FY25
millions USD
FY23:
−25.1
FY23:
−68.8
FY24:
−5.99
FY24:
−190
FY25:
75.5
Change from FY23 to FY25
millions USD
FY23:
32.0
FY23:
0
FY24:
20.3
FY24:
183
FY25:
−1.55
(positive)
Change from FY23 to FY25
millions USD
FY23:
−56.2
FY23:
−33.8
FY24:
−46.3
FY24:
11.9
FY25:
−73.7

All amounts in millions USD Data source:Twelve Data